Quantcast

Latest Biosimilar Stories

2014-09-10 20:24:21

LONDON, Sept. 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biotech API Manufacturing Services: World Industry and Market 2014-2024https://www.reportbuyer.com/product/2006105/Biotech-API-Manufacturing-Services-World-Industry-and-Market-2014-2024.html Report DetailsOutsourced biopharma production - new analysis announcing revenue prospectsWhat's the outlook for making biological active pharma ingredients (APIs) under contract? Visiongain's new report...

2014-09-10 16:25:54

DALLAS, September 10, 2014 /PRNewswire/ -- According to the new market research report "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Other Supplements, Device, Drug) - Global Forecast to 2023", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current...

2014-09-10 12:28:22

WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The following is a statement on behalf of RetireSafe: Dear Member of Congress; We write to you today to bring to your attention a critical safety issue that could affect all Americans, but especially those older Americans who rely on relatively new medicines called "biologics". RetireSafe, a 400,000-supporter strong nationwide advocacy organization for seniors, works hard to give a voice to retired Americans and those who hope to retire....

2014-09-10 08:31:13

IRVINE, Calif., Sept. 10, 2014 /PRNewswire/ -- Newly issued guidance by the Supreme Court has the potential to reshape the landscape of biologic drug and product commercialization, says Kyle J. Heppenstall, Managing Director of CompassX Consulting, a consultancy that focuses on architecting and executing strategies for Health executives. "Two recent Supreme Court decisions have emboldened the U.S. Patent and Trademark Office (USPTO) to announce that thousands of patents, if reviewed today,...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...

2014-08-27 12:31:23

Current Prescribers of Biosimilars Choose Between Biosimilar Products Based on the Manufacturer, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 27, 2014 /PRNewswire/ -- Decision Resources Group finds that physicians surveyed across six different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and nephrology) expect the robustness and number of clinical trials that a biosimilar has been assessed in to be the...

2014-08-20 23:09:43

The human insulin market is segmented based on types of insulin, and branded drugs available in the market (http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html). (PRWEB) August 20, 2014 The “Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019” provides a...

2014-08-20 23:08:43

The August issue of Atlantic Information Services’s Specialty Pharmacy News offers coverage of recent developments in the biosimilars specialty pharmacy segment, including the Food and Drug Administration’s recent acceptance of a biosimilar application, the first step towards approval. Washington, DC (PRWEB) August 20, 2014 Biosimilars, which are similar versions of branded biologic drugs that are approved through an abbreviated process, could reap billions in health care savings. The...

2014-08-18 12:27:41

DUBLIN, Aug. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "The Overveiw of Japanese Generic Drug Market" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report talks about the overview of Japanese generic drug market. It gives the readers ann understanding of the overall climate surrounding generic market in Japan. The report covers related regulations, generics's share in Japan, market size, primary makers, market trend,...

2014-08-14 16:27:44

Company To Pursue Next Stage of Development REDWOOD CITY, Calif., Aug. 14, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study that compared CHS-1420 to Humira(®) in healthy subjects. The parallel-group, single-dose study met the criteria for clinical PK similarity on all three required, prospectively defined,...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin